Healthcare Roundup – FDA OKs emergency use of Siemens COVID-19 blood test, Short regimen of Gilead’s remdesivir beats standard-of-care in COVID-19 study Life Science
Healthcare Roundup – Gilead not quite there with remdesivir nod in Europe, Chi-Med’s NDA for savolitinib accepted in China Life Science
Healthcare Roundup – Roche launches new studies of Actemra + remdesivir, CVS Health to achieve 1,000 COVID-19 sample collection sites Life Science
EdiGene and Immunochina Announce Research and Development Collaboration to Develop Allogeneic CAR-T Therapy for Cancer Life Science
Healthcare Roundup – PhaseBio gets FDA OK for clinical trial of COVID-19 treatment, Moderna correction pressures COVID-19 vaccine developers Life Science
Healthcare Roundup – Merck jumps into COVID-19 arena with three initiatives, Gilead picks up an upgrade on remdesivir upside Life Science
Healthcare Roundup – Novavax starts clinical trial of COVID-19 vaccine, Sanofi to shed 20.6% stake in Regeneron Life Science
Healthcare Roundup – FDA OKs Takeda’s brigatinib, Pfizer urges noteholders to reject offer by Huguenot Bond Liquidity Life Science
Apollomics, Inc. Announces Initiation of SPARTA Phase 2 Clinical Trial for c-MET Inhibitor APL-101 Life Science
